X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=aprovado-novo-medicamento-para-tratar-a-sindrome-de-sly&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=5025741&_101_INSTANCE_FXrpx9qY7FbU_type=content
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004438/WC500254546.pdf
http://www.pharmatimes.com/news/eu_oks_first_treatment_for_ultra_rare_lysosomal_storage_disorder_1250598
https://www.biopharma-reporter.com/Article/2018/06/01/CMO-Rentschler-signs-Ultragenyx-fill-finish-deal-for-US-supply
Market Place
Share 
